Lapides Asset Management’s Psychemedics Corporation PMD Stock Holding History

Lapides Asset Management’s Portfolio PMD Stock Details PMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-16,300	Closed	-$137K	–	82
2021 Q3	$137K	Sell	16,300 -400	-2%	-$2.93K	0.06%	77
2021 Q2	$116K	Sell	16,700 -4,600	-22%	-$32.2K	0.05%	78
2021 Q1	$132K	Buy	21,300 +9,100	+75%	+$60.3K	0.06%	72
2020 Q4	$62K	Sell	12,200 -11,000	-47%	-$47.7K	0.03%	67
2020 Q3	$102K	Buy	23,200 +4,600	+25%	+$22.4K	0.06%	62
2020 Q2	$103K	Buy	+18,600	New	+$104K	0.06%	60
2017 Q2	–	Sell	-10,700	Closed	-$215K	–	89
2017 Q1	$215K	Buy	+10,700	New	+$235K	0.04%	79
2016 Q1	–	Sell	-11,300	Closed	-$115K	–	86
2015 Q4	$115K	Buy	11,300 +300	+3%	+$3.27K	0.02%	86
2015 Q3	$111K	Buy	+11,000	New	+$128K	0.02%	87

Other funds holding PMD

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CIC

Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return

Lapides Asset Management's PMD Position: Q4 2021 in Review

Lapides Asset Management sold out of Psychemedics Corporation (PMD) in Q4 2021, closing a stake of 16,300 shares — an estimated $137K sold.

Lapides Asset Management first reported a position in PMD in Q3 2015 and held it in 9 quarters. The position peaked at $215K in Q1 2017. 25 funds tracked by Wall St. Rank hold PMD as of Q4 2021.

Lapides Asset Management reported no remaining Psychemedics Corporation position as of Q4 2021 after selling out during the quarter.
Lapides Asset Management sold 16,300 Psychemedics Corporation shares in Q4 2021, an estimated $137K.
Lapides Asset Management first reported a position in Psychemedics Corporation in Q3 2015 and held it in 9 quarters.
Lapides Asset Management's Psychemedics Corporation position peaked at $215K in Q1 2017.
25 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2021.

Based on Lapides Asset Management's 13F filing for Q4 2021, filed 31 Jan 2022.